What is the key to bridging the communication and trust gap between pharma and healthcare practitioners?

12 October 2018

doctor_communication_credit_depositphotos

Previous scandals and improvements in standards and transparency mean that the conversations and exchanges of information that take place between pharmaceutical companies and healthcare practitioners (HCPs) are now closely regulated in many countries.

One of the most strictly regulated environments in this regard is in the UK, where all contact that takes place between companies and health professionals is subject to a strict code of practice.

Pharma companies have to make sure that the actions of their employees and their representatives are perfectly responsible and transparent to avoid breaching the regulations, which are administered by the Prescription Medicines Code of Practice Authority on behalf of the Association of the British Pharmaceutical Industry.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK